Bin Jia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bin Jia has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Jinlong He
Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics; NHC Key Laboratory of Hormones and Development; Department of Physiology and Pathophysiology, Tianjin Medical University
3 shared publications - Jing Ren
Department of Orthopedics Combined TCM with Western Medicine, Honghui Hospital, Xi’an Jiaotong University, Xi’an, China
2 shared publications - Liang Qi
Shandong University of Science and Technology
2 shared publications - Shicheng Zheng
Department of Orthopedics Combined TCM with Western Medicine, Honghui Hospital, Xi’an Jiaotong University, Xi’an, China
2 shared publications - Yufeng Lu
Honghui Hospital,Xi'an Jiaotong University
2 shared publications - Baogang Zhang
Department of Diagnostic Pathology, School of Basic Medical Sciences, Shandong Second Medical University, Weifang, China
1 shared publication
Latest Publications
- Open Access
- 17 November 2022
- Published by Springer Nature in European Journal of Medical Research
- Vol. 27 (1) , 1-9
Correction of severe lower extremity deformity with digital hexapod external fixator based on CT data
Purpose: Our goal was to examine the therapeutic effect of a self-designed digital six-axis external fixator technique for the correction of severe lower extremity deformities. Patients and methods: Between January 2017 and December 2020, our institution employed self-developed digital hexapod external fixator technology (QSF), based on CT data, to gradually correct 28 severe tibial deformities, and 15 femurs underwent osteotomy and internal fixation. The mean patient age was 32.6 ± 14.3 years, and the mean follow-up duration was 27.4 ± 16.1 months. We also recoded and analyzed the values of preoperative and final follow-up MAD, mFTA, MPTA, LLD, mLDFA, LEFS, KSS, and functional score. Results: The QSF adjustment duration was 21.4 ± 10.8 days, and the healing duration of the tibial osteotomy site was 17.6 ± 7.0 weeks. The preoperative MAD, mFTA, and MPTA were 54.1 ± 26.2 mm, 167.7 ± 15.7°, and 75.2 ± 12.0°, respectively. At the last follow-up, the MAD was 8.2 ± 9.9 mm, mFTA was 177.6 ± 3.4°, and MPTA was 87.6 ± 2.4°. Based on these data, we achieved significant improvement post operation. The preoperative LLD and mLDFA values were 13.8 ± 18 mm and 83.7 ± 10.8°, respectively, and the values were 7.6 ± 7.6 mm and 87.8 ± 2.6°, respectively, at the last follow-up. This indicated no significant difference in these values before and after the operation. Finally, the LEFS, KSS, and functional scores improved from preoperative 51.6 ± 11.2, 68.5 ± 11.7, and 67.8 ± 11.2 to postoperative 72.3 ± 6.1, 92.9 ± 3.4, and 94.2 ± 6.3, respectively. Conclusions: Based on our analyses, the QSF technique accurately corrected severe multiplanar tibial deformities in adults. When combined with femoral osteotomy, satisfactory lower extremity alignment was obtained while correcting for femoral deformity. This technology has the advantages of simple operation, reliable fixation, less trauma, and less complications.
- 17 November 2022
- Published by Springer Nature in European Journal of Medical Research
- Vol. 27 (1) , 1-9
Open AccessCorrection of severe lower extremity deformity with digital hexapod external fixator based on CT data
Purpose: Our goal was to examine the therapeutic effect of a self-designed digital six-axis external fixator technique for the correction of severe lower extremity deformities. Patients and methods: Between January 2017 and December 2020, our institution employed self-developed digital hexapod external fixator technology (QSF), based on CT data, to gradually correct 28 severe tibial deformities, and 15 femurs underwent osteotomy and internal fixation. The mean patient age was 32.6 ± 14.3 years, and the mean follow-up duration was 27.4 ± 16.1 months. We also recoded and analyzed the values of preoperative and final follow-up MAD, mFTA, MPTA, LLD, mLDFA, LEFS, KSS, and functional score. Results: The QSF adjustment duration was 21.4 ± 10.8 days, and the healing duration of the tibial osteotomy site was 17.6 ± 7.0 weeks. The preoperative MAD, mFTA, and MPTA were 54.1 ± 26.2 mm, 167.7 ± 15.7°, and 75.2 ± 12.0°, respectively. At the last follow-up, the MAD was 8.2 ± 9.9 mm, mFTA was 177.6 ± 3.4°, and MPTA was 87.6 ± 2.4°. Based on these data, we achieved significant improvement post operation. The preoperative LLD and mLDFA values were 13.8 ± 18 mm and 83.7 ± 10.8°, respectively, and the values were 7.6 ± 7.6 mm and 87.8 ± 2.6°, respectively, at the last follow-up. This indicated no significant difference in these values before and after the operation. Finally, the LEFS, KSS, and functional scores improved from preoperative 51.6 ± 11.2, 68.5 ± 11.7, and 67.8 ± 11.2 to postoperative 72.3 ± 6.1, 92.9 ± 3.4, and 94.2 ± 6.3, respectively. Conclusions: Based on our analyses, the QSF technique accurately corrected severe multiplanar tibial deformities in adults. When combined with femoral osteotomy, satisfactory lower extremity alignment was obtained while correcting for femoral deformity. This technology has the advantages of simple operation, reliable fixation, less trauma, and less complications.
- Open Access
- 23 May 2022
- Published by Frontiers Media SA in Frontiers in Materials
- Vol. 9
Preparation and Photocatalytic and Antibacterial Activities of Micro/Nanostructured TiO2-Based Photocatalysts for Application in Orthopedic Implants
Micro/nanostructured TiO2, ion-doped TiO2, and heterojunction TiO2 composite photocatalysts have low toxicity, high biocompatibility, and high photocatalytic and antibacterial activities and have broad applications in the fields of photocatalytic, antibacterial, and orthopedic implants. The photocatalytic and antibacterial activities of TiO2 and TiO2-based photocatalysts depend on their preparation methods. In this review, the preparation methods of TiO2, ion-doped TiO2, and heterojunction TiO2 composite photocatalysts and their effects on photocatalytic and antibacterial activities were reviewed. Based on the excellent physical and chemical properties of TiO2, ion-doped TiO2, and heterojunction TiO2-based photocatalysts, their applications in the field of orthopedic implants were reviewed. Meanwhile, the development trend of the photocatalyst in the fields of photocatalysis, bacteriostasis, and medicine was prospected. The purpose of this review was to point out the direction for further study on photocatalytic and antibacterial activities and related applications of TiO2 and TiO2-based photocatalysts.
- 23 May 2022
- Published by Frontiers Media SA in Frontiers in Materials
- Vol. 9
Open AccessPreparation and Photocatalytic and Antibacterial Activities of Micro/Nanostructured TiO2-Based Photocatalysts for Application in Orthopedic Implants
Micro/nanostructured TiO2, ion-doped TiO2, and heterojunction TiO2 composite photocatalysts have low toxicity, high biocompatibility, and high photocatalytic and antibacterial activities and have broad applications in the fields of photocatalytic, antibacterial, and orthopedic implants. The photocatalytic and antibacterial activities of TiO2 and TiO2-based photocatalysts depend on their preparation methods. In this review, the preparation methods of TiO2, ion-doped TiO2, and heterojunction TiO2 composite photocatalysts and their effects on photocatalytic and antibacterial activities were reviewed. Based on the excellent physical and chemical properties of TiO2, ion-doped TiO2, and heterojunction TiO2-based photocatalysts, their applications in the field of orthopedic implants were reviewed. Meanwhile, the development trend of the photocatalyst in the fields of photocatalysis, bacteriostasis, and medicine was prospected. The purpose of this review was to point out the direction for further study on photocatalytic and antibacterial activities and related applications of TiO2 and TiO2-based photocatalysts.
- 3 April 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 360, 109921
E3 ubiquitin ligase ITCH improves LPS-induced chondrocyte injury by mediating JAG1 ubiquitination in osteoarthritis
- 3 April 2022
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 360, 109921
E3 ubiquitin ligase ITCH improves LPS-induced chondrocyte injury by mediating JAG1 ubiquitination in osteoarthritis
- Open Access
- 17 December 2019
- Published by Frontiers Media SA in Acta Biochimica Polonica
- Vol. 66 (4) , 463-467
Novel combinatorial transdermal drug delivery of alendronate with risedronate for the treatment of osteoporosis
The presented investigation explores the efficiency of novel transdermal drug delivery system of combination of two drugs i.e risedronate and alendronate in the treatment of osteoporosis. The nanoparticulate transdermal patch was prepared using PLGA as principle polymer which has been found to be suitable for drug delivery. The novel formulation system was found to be more efficient in lowering and maintaining the plasma calcium at a normal level when compared to a pure drug in a study carried out on an excised rat skin.
- 17 December 2019
- Published by Frontiers Media SA in Acta Biochimica Polonica
- Vol. 66 (4) , 463-467
Open AccessNovel combinatorial transdermal drug delivery of alendronate with risedronate for the treatment of osteoporosis
The presented investigation explores the efficiency of novel transdermal drug delivery system of combination of two drugs i.e risedronate and alendronate in the treatment of osteoporosis. The nanoparticulate transdermal patch was prepared using PLGA as principle polymer which has been found to be suitable for drug delivery. The novel formulation system was found to be more efficient in lowering and maintaining the plasma calcium at a normal level when compared to a pure drug in a study carried out on an excised rat skin.